Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-22

FDA Approved: CLOBAZAM — Original Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

FDA approved CLOBAZAM (clobazam) through an Original Abbreviated New Drug Application for Taro Pharmaceuticals U.S.A., Inc., representing a generic version of c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBAZAM (CLOBAZAM)

Snippet

ORIG AP for CLOBAZAM (CLOBAZAM)